AIS Healthcare is proud to announce that its two state-of-the-art 503A compounding pharmacies (Ridgeland, Mississippi; Dallas, Texas) which produce patient-specific prescriptions for targeted drug delivery (TDD), and its five Advanced Infusion Care locations (Valdosta, Georgia; Birmingham, Alabama; Clinton, Mississippi; Panama City, Florida; Dallas, Texas) have received the prestigious URAC accreditation for Specialty Pharmacy.

URAC is the independent leader in promoting healthcare quality through leadership, accreditation, measurement and innovation. By achieving re-accredited status, AIS Healthcare has demonstrated its commitment to going above and beyond to improve quality at every point along the care continuum.

“These accreditations are validation of what we do day in and day out—advancing quality,” said Michelle Wiest, Chief Operations Officer, AIS Healthcare. “It’s a prestigious recognition, and we’re proud to receive it for six of our leading pharmacies.”

AIS Healthcare is the leading targeted drug delivery and infusion care provider. In addition to compounding patient-specific prescriptions at its state-of-the-art 503A specialty pharmacies and providing personalized in-home infusion services, AIS Healthcare also offers a comprehensive suite of services to support both patients and providers.

“Throughout AIS Healthcare, we’re focused on doing more of what matters throughout the care continuum,” said Cindy Dumas, Vice President of Pharmacy Services and Pharmacist-in-Charge, Ridgeland. “This recognition from URAC shows how doing more to advance quality truly does result in meaningful improvements for patients and providers.”

AIS Healthcare is dually accredited by URAC and the Accreditation Commission for Health Care (ACHC), further setting it apart from other compounding pharmacies and infusion services providers.

The URAC accreditations for Specialty Pharmacy are effective through November 1, 2025.

 

Source:businesswire.com

Report Abuse